Cathie Wood's ARK Invest bought $17M in CRISPR and Beam gene-editing stocks while selling Teradyne, Roku, and SoFi shares on ...
1hon MSN
Tom Brady says he cloned his dog
Tom Brady's dog is a clone of a "beloved" family pet that died, the seven-time Super Bowl champion revealed on Tuesday. The ...
Canva unveils its Creative Operating System, blending AI, design, and marketing tools into one platform to launch the era of ...
We have written about the promise of gene therapy to correct genetic disease many times. An exciting development happened ...
NEW YORK – Azalea Therapeutics launched on Tuesday, having raised $82 million in seed and Series A financing to develop in vivo genetic medicines for cancer and autoimmune conditions using its ...
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge, gene-editing therapy fashioned ...
The grantmaking organization Open Philanthropy has awarded funding for a University of California San Diego technology ...
Recognized in the Biotechnology category of the 2025 Top Innovations contest, small Cas12l nucleases are versatile, ...
Amazon S3 on MSN
How gene editing could reshape the future of humans
CRISPR technology could one day create “designer babies, ” raising major ethical and social inequality concerns.
Azalea Therapeutics, Inc., a biotechnology company redefining precision genomic medicines in vivo, today announced its official launch and completion of $82 million in seed and Series A financing to ...
We’ve gone from asking, “How can we afford to make more videos?” to “How do we make sure the ones we already made are ...
A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback